Organoid Model Predictive of Response to Immunotherapies

Inclusion Criteria

• •1. ≥ 18 years old at the time of informed consent
• •2. Ability to provide written informed consent and HIPAA authorization
• •3. Biopsy proven diagnosis of cancer
• •4. Able to obtain at least 2 16 gage cores of fresh tissue safely (3 or more cores preferred)
• •5. Planning to undergo standard of care Immunotherapy
• •6. Baseline standard of care CT within 8 weeks of starting Immunotherapy